Veopoz Side Effects

Generic name: pozelimab

Medically reviewed by Drugs.com. Last updated on Feb 4, 2025.

Note: This document provides detailed information about Veopoz Side Effects associated with pozelimab. Some dosage forms listed on this page may not apply specifically to the brand name Veopoz.

Applies to pozelimab: parenteral injection for iv or sub-q use.

Important warnings This medicine can cause some serious health issues

Serious Meningococcal Infections
• Life-threatening and fatal meningococcal infections reported in patients treated with complement inhibitors; such infections can become rapidly life-threatening or fatal if not recognized and treated early.¹

• Complete or update meningococcal vaccinations ≥2 weeks prior to administering first dose of pozelimab-bbfg, unless risks of delaying therapy outweigh those of developing meningococcal infection.¹ Follow the most current Advisory Committee on Immunization Practices (ACIP) recommendations for meningococcal vaccination in patients receiving a complement inhibitor.¹

• Patients receiving pozelimab-bbfg at increased risk for invasive disease due to Neisseria meningitidis, even if they develop antibodies following vaccination.¹

• Monitor patients for early signs of meningococcal infections; evaluate immediately if infection suspected.¹

Side effects include:

Adverse effects reported in ≥2 patients include upper respiratory tract infection, fracture, urticaria, alopecia.

For healthcare professionals

Applies to pozelimab: injectable solution.

General adverse events

Most common adverse reactions were upper respiratory tract infection, fracture, urticaria, and alopecia.^[Ref]

Cardiovascular

• Frequency not reported: Elevated systolic blood pressure, elevated diastolic blood pressure^[Ref]

Dermatologic

• Very common (10% or more): Urticaria (20%), alopecia (20%)^[Ref]

Gastrointestinal

• Frequency not reported: Gingival bleeding^[Ref]

Hypersensitivity

• Frequency not reported: Systemic hypersensitivity reactions, immune complex formation^[Ref]

Local

• Frequency not reported: Injection site reactions (included dermatitis and erythema)^[Ref]

Metabolic

• Frequency not reported: Metabolic acidosis, increased blood uric acid^[Ref]

Musculoskeletal

• Very common (10% or more): Fracture (30%)^[Ref]

Nervous system

• Frequency not reported: Serious meningococcal infections^[Ref]

Other

• Frequency not reported: Bacterial infections^[Ref]

Respiratory

• Very common (10% or more): Upper respiratory tract infection (30%)^[Ref]

Genitourinary

• Frequency not reported: Hematuria, proteinuria^[Ref]

Hepatic

• Frequency not reported: Increased liver enzymes^[Ref]

Further information

Veopoz side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer